Eli Lilly (LLY) Prepaid Assets (2009 - 2026)

Eli Lilly (LLY) posted Prepaid Assets of $214.0 million for Q1 2026, down 98.51% quarter-over-quarter from $14.3 billion in Q4 2025, and down 98.54% year-on-year from $14.7 billion in Q1 2025.

Eli Lilly (LLY) Prepaid Assets (2009 - 2026) Analysis & Trends

Eli Lilly (LLY) has reported Prepaid Assets for 18 consecutive years, with $214.0 million the latest figure, recorded in Q1 2026.

  • Prepaid Assets for Q1 2026 came in at $214.0 million, down 98.54% year-over-year; the trailing twelve-month figure through Mar 2026 was $214.0 million (down 98.54% YoY), and the FY2025 annual result was $14.3 billion, up 5281.58% from the prior year.
  • Prepaid Assets was $214.0 million for Q1 2026 at Eli Lilly, down from $14.3 billion in the prior quarter.
  • Over five years, Prepaid Assets peaked at $20.2 billion in Q3 2025 and troughed at $7.3 million in Q4 2022.
  • Average Prepaid Assets over 5 years is $4.6 billion, with a median of $2.7 billion recorded in 2022.
  • Year-over-year, Prepaid Assets sank 99.71% in 2022 and surged 14943.61% in 2025.
  • Over 5 years, Prepaid Assets stood at $7.3 million in 2022, then soared by 1947.95% to $149.5 million in 2023, then jumped by 77.93% to $266.0 million in 2024, then jumped by 5281.58% to $14.3 billion in 2025, then sank by 98.51% to $214.0 million in 2026.
  • Per Business Quant data, the three most recent Prepaid Assets figures were $214.0 million in Q1 2026, $14.3 billion in Q4 2025, and $20.2 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn
9 Novartis Ag 113.45 Bn 113.67 Bn -
10 Biogen 30.87 Bn 26.59 Bn 1.82 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 214.00 Mn
Dec 31, 2025 14.32 Bn
Sep 30, 2025 20.25 Bn
Jun 30, 2025 68.80 Mn
Mar 31, 2025 14.65 Bn
Dec 31, 2024 266.00 Mn
Sep 30, 2024 134.60 Mn
Jun 30, 2024 142.20 Mn
Mar 31, 2024 6.35 Bn
Dec 31, 2023 149.50 Mn
Sep 30, 2023 5.25 Bn
Jun 30, 2023 4.53 Bn
Mar 31, 2023 3.58 Bn
Dec 31, 2022 7.30 Mn
Sep 30, 2022 2.74 Bn
Jun 30, 2022 2.81 Bn
Mar 31, 2022 2.70 Bn
Dec 31, 2021 2.53 Bn
Sep 30, 2021 3.05 Bn
Jun 30, 2021 3.30 Bn